For instance, Freitas and his colleagues discovered promoter methylation of the three-genes panel (MGMT, RASSF1A, and SEPT9) in accurately diagnosed CRC with 96.6% sensitivity and 74% specificity of detection [13]. Here, SEPTIN9 is linked to colorectal carcinoma.